Table of Contents

July 1, 2019; Volume 60,Issue 7

  1. Fayad, Zahi A.

    1. Advanced Imaging in Cardiac Sarcoidosis
      Roberto Ramirez, Maria Trivieri, Zahi A. Fayad, Amir Ahmadi, Jagat Narula and Edgar Argulian
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 892-898; DOI: https://doi.org/10.2967/jnumed.119.228130

  2. Fendler, Wolfgang Peter

    1. Impact of 68Ga-PSMA PET/CT on the Radiotherapeutic Approach to Prostate Cancer in Comparison to CT: A Retrospective Analysis
      Nina-Sophie Schmidt-Hegemann, Chukwuka Eze, Minglun Li, Paul Rogowski, Christian Schaefer, Christian Stief, Alexander Buchner, Constantinos Zamboglou, Wolfgang Peter Fendler, Ute Ganswindt, Clemens Cyran, Peter Bartenstein, Claus Belka and Harun Ilhan
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 963-970; DOI: https://doi.org/10.2967/jnumed.118.220855

  3. Flavell, Robert R.

    1. Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer
      Spencer C. Behr, Rahul Aggarwal, Henry F. VanBrocklin, Robert R. Flavell, Kenneth Gao, Eric J. Small, Joseph Blecha, Salma Jivan, Thomas A. Hope, Jeffry P. Simko, John Kurhanewicz, Susan M. Noworolski, Natalie J. Korn, Romelyn De Los Santos, Matthew R. Cooperberg, Peter R. Carroll, Hao G. Nguyen, Kirsten L. Greene, Beatrice Langton-Webster, Clifford E. Berkman and Youngho Seo
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 910-916; DOI: https://doi.org/10.2967/jnumed.118.220715

  4. Foster, Julie

    1. DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use
      Maximilian Klingler, Dominik Summer, Christine Rangger, Roland Haubner, Julie Foster, Jane Sosabowski, Clemens Decristoforo, Irene Virgolini and Elisabeth von Guggenberg
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 1010-1016; DOI: https://doi.org/10.2967/jnumed.118.221283

  5. Franssen, Gerben M.

    1. In Vitro and In Vivo Characterization of an 18F-AlF-Labeled PSMA Ligand for Imaging of PSMA-Expressing Xenografts
      Susanne Lütje, Gerben M. Franssen, Ken Herrmann, Otto C. Boerman, Mark Rijpkema, Martin Gotthardt and Sandra Heskamp
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 1017-1022; DOI: https://doi.org/10.2967/jnumed.118.218941

  6. Freedman, Immanuel

    1. Open Access
      Immuno-PET Imaging to Assess Target Engagement: Experience from 89Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid Tumors
      C. Willemien Menke-van der Houven van Oordt, Adam McGeoch, Mats Bergstrom, Iain McSherry, Deborah A. Smith, Matthew Cleveland, Wasfi Al-Azzam, Liangfu Chen, Henk Verheul, Otto S. Hoekstra, Danielle J. Vugts, Immanuel Freedman, Marc Huisman, Chris Matheny, Guus van Dongen and Sean Zhang
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 902-909; DOI: https://doi.org/10.2967/jnumed.118.214726

  7. Fu, Yao

    1. Combination of 68Ga-PSMA PET/CT and Multiparametric MRI Improves the Detection of Clinically Significant Prostate Cancer: A Lesion-by-Lesion Analysis
      Mengxia Chen, Qing Zhang, Chengwei Zhang, Xiaozhi Zhao, Giancarlo Marra, Jie Gao, Xiaoyu Lv, Bing Zhang, Yao Fu, Feng Wang, Xuefeng Qiu and Hongqian Guo
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 944-949; DOI: https://doi.org/10.2967/jnumed.118.221010

  8. Fu, Zhequan

    1. P2X7 PET Radioligand 18F-PTTP for Differentiation of Lung Tumor from Inflammation
      Zhequan Fu, Qingyu Lin, Bingxin Hu, Yingying Zhang, Weijia Chen, Jing Zhu, Yanzhao Zhao, Hak Soo Choi, Hongcheng Shi and Dengfeng Cheng
      Journal of Nuclear Medicine July 1, 2019, 60 (7) 930-936; DOI: https://doi.org/10.2967/jnumed.118.222547
Back to top

In this issue